NO20003246D0 - Nye farmasøytiske preparater av uridintrifosfat - Google Patents
Nye farmasøytiske preparater av uridintrifosfatInfo
- Publication number
- NO20003246D0 NO20003246D0 NO20003246A NO20003246A NO20003246D0 NO 20003246 D0 NO20003246 D0 NO 20003246D0 NO 20003246 A NO20003246 A NO 20003246A NO 20003246 A NO20003246 A NO 20003246A NO 20003246 D0 NO20003246 D0 NO 20003246D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- new pharmaceutical
- uridine triphosphate
- uridine
- triphosphate
- Prior art date
Links
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229950010342 uridine triphosphate Drugs 0.000 title 1
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/996,740 US5968913A (en) | 1996-07-03 | 1997-12-23 | Pharmaceutical compositions of uridine triphosphate |
| PCT/US1998/027409 WO1999032085A2 (en) | 1997-12-23 | 1998-12-23 | Novel pharmaceutical compositions of uridine triphosphate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003246D0 true NO20003246D0 (no) | 2000-06-21 |
| NO20003246L NO20003246L (no) | 2000-08-23 |
Family
ID=25543248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003246A NO20003246L (no) | 1997-12-23 | 2000-06-21 | Nye farmasøytiske preparater av uridintrifosfat |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5968913A (no) |
| EP (1) | EP1041969B1 (no) |
| JP (1) | JP2001526208A (no) |
| KR (1) | KR20010033310A (no) |
| CN (1) | CN1143672C (no) |
| AR (1) | AR014176A1 (no) |
| AT (1) | ATE235225T1 (no) |
| AU (1) | AU747350B2 (no) |
| BR (1) | BR9814426A (no) |
| CA (1) | CA2316018A1 (no) |
| DE (1) | DE69812708T2 (no) |
| ID (1) | ID26137A (no) |
| IL (1) | IL136895A0 (no) |
| NO (1) | NO20003246L (no) |
| NZ (1) | NZ505821A (no) |
| WO (1) | WO1999032085A2 (no) |
| ZA (1) | ZA9811833B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
| WO1999005155A2 (en) | 1997-07-25 | 1999-02-04 | Inspire Pharmaceuticals, Inc. | Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7452870B2 (en) | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US6327215B1 (en) * | 2000-09-28 | 2001-12-04 | Vanguard International Semiconductor Corporation | Local bit switch decode circuit and method |
| JP2005508297A (ja) | 2001-06-25 | 2005-03-31 | インスパイアー ファーマシューティカルズ，インコーポレイティド | Ｐ２ｙプリン受容体作用物質による関節潤滑 |
| JP2005532254A (ja) * | 2001-11-06 | 2005-10-27 | インスパイアー ファーマシューティカルズ，インコーポレイティド | 炎症性疾患を治療又は予防する方法 |
| JP2006505585A (ja) * | 2002-10-18 | 2006-02-16 | モリケム メディシンズ， インコーポレイテッド | ランチビオティクスで眼乾燥症を処置する方法 |
| EP1753445A4 (en) * | 2004-05-06 | 2009-05-20 | Molichem Medicines Inc | TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS |
| WO2005107787A1 (en) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
| US20120077778A1 (en) * | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| EP2556832B1 (en) | 2011-08-12 | 2017-07-19 | Universitätsklinikum Freiburg | Uridine and uridine analogues for use in the treatment of chronic obstructive pulmonary disease |
| US9034442B2 (en) * | 2012-11-30 | 2015-05-19 | Corning Incorporated | Strengthened borosilicate glass containers with improved damage tolerance |
| US10117806B2 (en) * | 2012-11-30 | 2018-11-06 | Corning Incorporated | Strengthened glass containers resistant to delamination and damage |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB916309A (en) * | 1959-12-14 | 1963-01-23 | Ile Auguil Soc Civ | Improvements in and relating to new therapeutic preparation for use as a muscular and nervous stimulant |
| JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
| GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
| US5164740A (en) * | 1991-04-24 | 1992-11-17 | Yehuda Ivri | High frequency printing mechanism |
| FR2677250B1 (fr) * | 1991-06-05 | 1995-01-20 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. |
| EP0517573A1 (fr) * | 1991-06-05 | 1992-12-09 | Synthelabo | Compositions pharmaceutiques pour le traitement des affections des voies respiratoires |
| US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| ATE131421T1 (de) * | 1991-12-04 | 1995-12-15 | The Technology Partnership Plc | Vorrichtung und verfahren zur erzeugung von fluessigkeitstroepfchen |
| US5547131A (en) * | 1992-12-04 | 1996-08-20 | Bespak Plc | Dispensing device with spray nozzle and driven piston |
| US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| US5593824A (en) * | 1994-09-02 | 1997-01-14 | Pharmacia Biotech, Inc. | Biological reagent spheres |
| US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| US6423694B1 (en) * | 1996-02-21 | 2002-07-23 | Inspire Pharmaceuticals, Inc. | Method of treating otitis media with uridine triphosphates and related compounds |
| EP0889728B1 (en) * | 1996-03-27 | 2006-08-09 | Inspire Pharmaceuticals, Inc. | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| US5962432A (en) * | 1996-07-03 | 1999-10-05 | Inspire Pharmaceuticals, Inc. | Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate |
| US5789391A (en) * | 1996-07-03 | 1998-08-04 | Inspire Pharmaceuticals, Inc. | Method of treating sinusitis with uridine triphosphates and related compounds |
| US5763447C1 (en) * | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| US6159952A (en) * | 1996-11-07 | 2000-12-12 | Inspire Pharmaceuticals, Inc. | Method of treating bronchitis with uridine triphosphate and related compounds |
-
1997
- 1997-12-23 US US08/996,740 patent/US5968913A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 EP EP98965462A patent/EP1041969B1/en not_active Expired - Lifetime
- 1998-12-23 DE DE69812708T patent/DE69812708T2/de not_active Expired - Fee Related
- 1998-12-23 KR KR1020007006756A patent/KR20010033310A/ko not_active Abandoned
- 1998-12-23 WO PCT/US1998/027409 patent/WO1999032085A2/en not_active Ceased
- 1998-12-23 ZA ZA9811833A patent/ZA9811833B/xx unknown
- 1998-12-23 CN CNB988136228A patent/CN1143672C/zh not_active Expired - Fee Related
- 1998-12-23 IL IL13689598A patent/IL136895A0/xx unknown
- 1998-12-23 NZ NZ505821A patent/NZ505821A/xx unknown
- 1998-12-23 CA CA002316018A patent/CA2316018A1/en not_active Abandoned
- 1998-12-23 JP JP2000525079A patent/JP2001526208A/ja active Pending
- 1998-12-23 AU AU20922/99A patent/AU747350B2/en not_active Ceased
- 1998-12-23 BR BR9814426-0A patent/BR9814426A/pt not_active IP Right Cessation
- 1998-12-23 ID IDW20001428A patent/ID26137A/id unknown
- 1998-12-23 AR ARP980106670A patent/AR014176A1/es not_active Application Discontinuation
- 1998-12-23 AT AT98965462T patent/ATE235225T1/de not_active IP Right Cessation
-
2000
- 2000-06-21 NO NO20003246A patent/NO20003246L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ505821A (en) | 2002-09-27 |
| WO1999032085A3 (en) | 1999-09-02 |
| ATE235225T1 (de) | 2003-04-15 |
| AU2092299A (en) | 1999-07-12 |
| CN1143672C (zh) | 2004-03-31 |
| EP1041969A2 (en) | 2000-10-11 |
| EP1041969B1 (en) | 2003-03-26 |
| AR014176A1 (es) | 2001-02-07 |
| AU747350B2 (en) | 2002-05-16 |
| CN1284861A (zh) | 2001-02-21 |
| JP2001526208A (ja) | 2001-12-18 |
| CA2316018A1 (en) | 1999-07-01 |
| IL136895A0 (en) | 2001-06-14 |
| US5968913A (en) | 1999-10-19 |
| WO1999032085A2 (en) | 1999-07-01 |
| DE69812708T2 (de) | 2004-01-29 |
| DE69812708D1 (de) | 2003-04-30 |
| NO20003246L (no) | 2000-08-23 |
| KR20010033310A (ko) | 2001-04-25 |
| ZA9811833B (en) | 1999-07-20 |
| ID26137A (id) | 2000-11-23 |
| BR9814426A (pt) | 2001-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003246D0 (no) | Nye farmasøytiske preparater av uridintrifosfat | |
| IS5953A (is) | Lyfjablöndur úr örgerðum eplerenonum | |
| FI973278A7 (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| BR9610153A (pt) | Formulações farmacêuticas | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| IS4644A (is) | Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra | |
| DE69831620D1 (de) | Arzneizubereitungen enthaltend Kannabinoide | |
| ATE246490T1 (de) | Pharmazeutische zusammensetzung von topiramate | |
| DK0981375T3 (da) | Farmaceutiske præparater indeholdende plasmaprotein | |
| IS5245A (is) | Lyfjablanda úr ómeprasól | |
| ATE238812T1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
| PT858325E (pt) | Formulacao farmaceutica liofilizada estavel | |
| NO20002835D0 (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
| PT1006110E (pt) | Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos | |
| DK1007030T3 (da) | Fast farmaceutisk præparat indeholdende benzofuranderivater | |
| BR9610396A (pt) | Formulação farmacêutica | |
| BR9606674A (pt) | Novo derivado de composto de antraciclina e preparação farmacéutica contendo o mesmo | |
| NO994659D0 (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende slike | |
| IT1276799B1 (it) | Formulazioni di f-silicone | |
| DE69926012D1 (de) | Arzneizubereitungen | |
| FI973229L (fi) | Uusi farmaseuttinen koostumus | |
| NO995838D0 (no) | Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme | |
| DK1041966T3 (da) | Farmaceutiske præparater omfattende zafirlukast | |
| FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
| DE69906934D1 (de) | Arzneizubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |